CoChat

Effectiveness of the psychological and pharmacological treatment of catastrophization in patients with fibromyalgia: a randomized controlled trial.

Open access
García-Campayo, Javier, Serrano-Blanco, Antoni, Rodero, Baltasar, Magallón, Rosa, Alda, Marta, Andrés, Eva, Luciano, Juan V, del Hoyo, Yolanda López · 2009 · Trials

The DOI matches its Crossref record; 46 of the 47 references it cites were found in a registry or an index; 3 of the 32 sources its claims cite were checked for support.

Abstract

Background: Fibromyalgia is a prevalent and disabling disorder characterized by widespread pain and other symptoms such as insomnia, fatigue or depression. Catastrophization is considered a key clinical symptom in fibromyalgia; however, there are no studies on the pharmacological or psychological treatment of catastrophizing. The general aim of this study is to assess the effectiveness of cognitive-behaviour therapy and recommended pharmacological treatment for fibromyalgia (pregabalin, with duloxetine added where there is a comorbid depression), compared with usual treatment at primary care level.Method/design: Design: A multi-centre, randomized controlled trial involving three groups: the control group, consisting of usual treatment at primary care level, and two intervention groups, one consisting of cognitive-behaviour therapy, and the other consisting of the recommended pharmacological treatment for fibromyalgia.Setting: 29 primary care health centres in the city of Zaragoza, Spain.Sample: 180 patients, aged 18-65 years, able to understand and read Spanish, who fulfil criteria for primary fibromyalgia, with no previous psychological treatment, and no pharmacological treatment or their acceptance to discontinue it two weeks before the onset of the study.Intervention: Psychological treatment is based on the manualized protocol developed by Prof. Escobar et al, from the University of New Jersey, for the treatment of somatoform disorders, which has been adapted by our group for the treatment of fibromyalgia. It includes 10 weekly sessions of cognitive-behaviour therapy. Pharmacological therapy consists of the recommended pharmacological treatment for fibromyalgia: pregabalin (300-600 mg/day), with duloxetine (60-120 mg/day) added where there is a comorbid depression).Measurements: The following socio-demographic data will be collected: sex, age, marital status, education, occupation and social class. The diagnosis of psychiatric disorders will be made with the Structured Polyvalent Psychiatric Interview. Other instruments to be administered are the Pain Catastrophizing Scale, the Hamilton tests for Anxiety and for Depression, the Fibromyalgia Impact Questionnaire (FIQ), the EuroQuol-5 domains (EQ-5D), and the use of health and social services (CSRI). Assessments will be carried out at baseline, 1, 3, and 6 months. MAIN VARIABLE: Pain catastrophizing.Analysis: The analysis will be per intent to treat. We will use the general linear models of the SPSS version 15 statistical package, to analyse the effect of the treatment on the result variable (pain catastrophizing).Discussion: It is necessary to assess the effectiveness of pharmacological and psychological treatments for pain catastrophizing in fibromyalgia. This randomized clinical trial will determine whether both treatments are effective for this important prognostic variable in patients with fibromyalgia.Trial Registration: Current Controlled Trials ISRCTN10804772.

Overview

CoChat Summary

## TL;DR

This paper describes a multicentre randomized controlled trial to test whether cognitive-behaviour therapy or recommended pharmacological treatment reduces pain catastrophizing in fibromyalgia compared with usual primary care. At the time of the paper, it reports the trial protocol, not results.

## Key findings

  • The study is designed as a three-arm randomized controlled trial with 180 patients total, 60 per group, comparing usual care, 10 weekly CBT sessions, and pregabalin 300–600 mg/day with duloxetine 60–120 mg/day added for comorbid depression.
  • The main outcome is pain catastrophizing, measured with the Spanish version of the Pain Catastrophizing Scale.
  • Follow-up assessments are scheduled at baseline, 1, 3, and 6 months.
  • The authors state that the trial aims to detect a 20% or greater difference between groups, using alpha 0.05 and beta < 0.20; this implies 55 patients per group, increased to 60 to allow for 10% refusals.

## Methods

  • Design: Multicentre randomized controlled trial with three branches: CBT, recommended pharmacological treatment, and treatment as usual in primary care; allocation is computer-generated and concealed.
  • Sample/data: Recruitment from 29 primary care health centres in Zaragoza, Spain; eligible patients are 18–65 years, Spanish-reading, meet criteria for primary fibromyalgia, and have no prior psychological treatment and no current pharmacological treatment unless they agree to stop it 2 weeks before study start.
  • Analysis: Planned intention-to-treat analysis using Kruskal-Wallis and chi-squared tests for baseline comparisons, general linear models for the main outcome, and linear mixed models for continuous process variables; cost-utility analysis will use gamma regression, OLS regressions, and 5,000 bootstrap replications.

## Limitations

  • The paper states that there are no prior published studies on pharmacological or psychological treatment of catastrophizing in fibromyalgia, so the sample-size estimate is based on clinical experience rather than prior effect data.
  • The authors note potential difficulties in recruitment because patients must discontinue pharmacological treatment, and potential changes in employment status may make results harder to interpret.
  • Evident from the text: this is a protocol paper, so it reports planned methods and expected dates, not trial outcomes.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1186/1745-6215-10-24

Cites

46 of 46 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Figure 1 Flowchart: randomization, sampling and monitoring of patients.
Figure 1 Flowchart: randomization, sampling and monitoring of patients.CC BY · PubMed Central

Verification

Claims the paper makes

3 Valid · 0 Not valid · 23 Not checked · 9 Own results and interpretations

1 reference still to check

A free account verifies the references that are still open.

Verify 1 reference — free account
  • Probably not a substantial claim. 27
  • It may state two separate claims as one. 12

Create a free account to see these claims.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

1 more claim about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Citations

Cites

Show all 46 references

Cited by

See all 30

Metadata

Authors
García-Campayo, J., Serrano-Blanco, A., Rodero, B., Magallón, R., Alda, M., Andrés, E., Luciano, J. V., & del Hoyo, Y. L.
Affiliations
Red de Investigación en Actividades Preventivas y Promoción de la Salud (ES)
Venue
Trials
Published
2009-04-23
Volume
10
Issue
1
Pages
24-24
ISSN
1745-6215 (ISSN-L)
OpenAlex
W2168655355
Cited by
30
References
47
Citations by year
2026: 1 · 2021: 1 · 2018: 2 · 2017: 3 · 2016: 2 · 2015: 2 · 2014: 4 · 2013: 3 · 2012: 4
FWCI
2.47
Type
journal article
Language
en
Open access
Licence
  • cc-by
  • creativecommons.org/licenses/by/2.0 (tdm)
Locations
  • Trials (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
Funders
Instituto de Salud Carlos III
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Fibromyalgia and Chronic Fatigue Syndrome Research
  • Health Sciences › Health Professions › Physical Therapy, Sports Therapy and Rehabilitation › Musculoskeletal pain and rehabilitation
  • Health Sciences › Medicine › Psychiatry and Mental health › Psychosomatic Disorders and Their Treatments
Keywords
fibromyalgia, pain catastrophizing, cognitive behavioral therapy, pregabalin, duloxetine, comorbid depression, primary care, treatment effectiveness, somatoform disorders, health-related quality of life, health care utilization, pain intensity, anxiety, primary fibromyalgia, usual care comparison, health technology assessment, cost-effectiveness
MeSH terms
Duloxetine Hydrochloride, Pregabalin, Adolescent, Adult, Aged, Analgesics, Antidepressive Agents, Combined Modality Therapy, Depression, Fibromyalgia, gamma-Aminobutyric Acid, Humans, Middle Aged, Pain, Pain Measurement, Psychiatric Status Rating Scales, Research Design, Spain, Thiophenes, Time Factors, Cognitive Behavioral Therapy, Treatment Outcome, Young Adult, Pain Management

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Effectiveness of the psychological and pharmacological treatment of catastrophization in patients with fibromyalgia: a randomized controlled trial. https://app.cochat.ai/papers/10.1186/1745-6215-10-24
The paper
García-Campayo, J., Serrano-Blanco, A., Rodero, B., Magallón, R., Alda, M., Andrés, E., Luciano, J. V., & del Hoyo, Y. L. (2009). Effectiveness of the psychological and pharmacological treatment of catastrophization in patients with fibromyalgia: a randomized controlled trial. Trials. https://doi.org/10.1186/1745-6215-10-24

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.